Pnc Financial Services Group, Inc. Pmv Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 69,113 shares of PMVP stock, worth $99,522. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69,113
Previous 69,229
0.17%
Holding current value
$99,522
Previous $103,000
0.97%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PMVP
# of Institutions
81Shares Held
42.9MCall Options Held
3.1KPut Options Held
1.7K-
Orbimed Advisors LLC San Diego, CA6.48MShares$9.32 Million0.23% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.65MShares$5.25 Million0.08% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.47MShares$4.99 Million3.25% of portfolio
-
Sio Capital Management, LLC New York, NY3.21MShares$4.63 Million2.53% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$3.78 Million0.43% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $65.7M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...